Mergers & Acquisitions
April 29, 2025
Border
Less than
min read

Germany's Merck in $3.9bn deal to buy US biotech firm SpringWorks

Germany's Merck in $3.9bn deal to buy US biotech firm SpringWorks
Close Icon